Content about pyridoxine hydrochloride

May 21, 2013

Drug maker Duchesnay USA has launched a new treatment for morning sickness, the company announced.

ROSEMONT, Pa. — Drug maker Duchesnay USA has launched a new treatment for morning sickness, the company said Tuesday.

April 9, 2013

The Food and Drug Administration has approved a drug for treating nausea and vomiting during pregnancy.

ROSEMONT, Pa. — The Food and Drug Administration has approved a drug for treating nausea and vomiting during pregnancy.

Drug maker Duchesnay USA said the FDA approved Diclegis (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets in the 10 mg/10 mg strength for NVP, more commonly known as morning sickness, in women who don't respond to conservative treatment. NVP is estimated to affect 70-85% of pregnant women, and symptoms range from nausea to severe vomiting and retching that can last throughout the day.